1913-28-6 Usage
Type of hormone
Synthetic steroid hormone
Derivative
Progesterone
Primary use
Progestin to treat hormonal imbalances and regulate menstrual cycle
Additional uses
Assisted reproduction techniques and contraception
Mechanism of action
Binds to progesterone receptors, modulating physiological processes
Physiological processes affected
Uterine lining, ovulation, and embryo implantation
Investigated for
Treatment of endometriosis and breast cancer
Side effects
Potential side effects exist, as with all medications
Usage guidance
Should be used under the supervision of a healthcare professional
Chemical structure
Modified from progesterone with an additional oxygen atom at the 11 and 19 positions
Administration
Typically administered orally or through injection
Storage
Should be stored at room temperature, away from moisture, heat, and light
Drug interactions
May interact with other medications, including other hormonal therapies, anticonvulsants, and some antibiotics. A healthcare professional should be consulted for a complete list of potential interactions.
Check Digit Verification of cas no
The CAS Registry Mumber 1913-28-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,9,1 and 3 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1913-28:
(6*1)+(5*9)+(4*1)+(3*3)+(2*2)+(1*8)=76
76 % 10 = 6
So 1913-28-6 is a valid CAS Registry Number.
InChI:InChI=1/C21H28O3/c1-12(22)16-5-6-17-15-4-3-13-9-14(23)7-8-21(13)11-24-18(19(15)21)10-20(16,17)2/h9,15-19H,3-8,10-11H2,1-2H3/t15-,16+,17-,18?,19+,20+,21+/m0/s1
1913-28-6Relevant articles and documents
An Improved Preparation of 11,19-Oxidopregn-4-ene-3,20-dione and 6,19-Oxidopregn-4-ene-3,11,20-trione
Brachet-Cota, Adriana L.,Burton, Gerardo
, p. 711 - 715 (2007/10/02)
A synthesis of 11,19-oxidopregn-4-ene-3,20-dione and 6,19-oxidopregn-4-ene-3,11,20-trione is described starting from pregn-4-ene-3,11,20-trione and via the common intermediate 3β,20β-diacetyloxy-5α-bromo-6,19-oxidopregnan-11-one, in 30 and 32percent yield, respectively.
